MY7800234A - Novel triamcinolone derivative - Google Patents

Novel triamcinolone derivative

Info

Publication number
MY7800234A
MY7800234A MY234/78A MY7800234A MY7800234A MY 7800234 A MY7800234 A MY 7800234A MY 234/78 A MY234/78 A MY 234/78A MY 7800234 A MY7800234 A MY 7800234A MY 7800234 A MY7800234 A MY 7800234A
Authority
MY
Malaysia
Prior art keywords
triamcinolone derivative
novel triamcinolone
novel
derivative
triamcinolone
Prior art date
Application number
MY234/78A
Other languages
English (en)
Inventor
Walter Shultz
George Madison Sieger
Charles Krieger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of MY7800234A publication Critical patent/MY7800234A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY234/78A 1973-08-17 1978-12-30 Novel triamcinolone derivative MY7800234A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38930273A 1973-08-17 1973-08-17

Publications (1)

Publication Number Publication Date
MY7800234A true MY7800234A (en) 1978-12-31

Family

ID=23537694

Family Applications (1)

Application Number Title Priority Date Filing Date
MY234/78A MY7800234A (en) 1973-08-17 1978-12-30 Novel triamcinolone derivative

Country Status (17)

Country Link
US (1) US4158055A (nl)
JP (1) JPS557407B2 (nl)
BE (1) BE818929A (nl)
CH (1) CH601353A5 (nl)
CY (1) CY946A (nl)
DE (1) DE2437847C3 (nl)
FR (1) FR2240738B1 (nl)
GB (1) GB1442925A (nl)
HK (1) HK44778A (nl)
HU (1) HU172213B (nl)
IE (1) IE39738B1 (nl)
IL (1) IL45200A (nl)
KE (1) KE2820A (nl)
MY (1) MY7800234A (nl)
NL (1) NL184899C (nl)
PH (1) PH12415A (nl)
ZA (1) ZA744259B (nl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA763131B (en) * 1975-05-27 1978-01-25 Syntex Inc Use of flunisolide to treat respiratory diseases
DE10326899A1 (de) * 2003-06-14 2004-12-30 Beiersdorf Ag Kosmetische Zubereitungen mit stabilisierten Konservierungsmitteln
BRPI0413330A (pt) * 2003-08-29 2006-10-10 Ranbaxy Lab Ltd inibidores de fosfodiesterase do tipo iv, composição farmacêutica contendo os mesmos e processo para sua preparação
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN101616901A (zh) * 2006-09-22 2009-12-30 兰贝克赛实验室有限公司 Iv型磷酸二酯酶的抑制剂
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
CN103497185A (zh) * 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN113698448B (zh) * 2021-10-29 2022-02-22 山东谷雨春生物科技有限公司 一种安西奈德的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894810A (en) * 1959-10-05 1962-04-26 American Cyanamid Co Aqueous pharmaceutical solutions containing anti-inflammatory steroids
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
GB928150A (en) * 1961-02-08 1963-06-06 Upjohn Co Topical pharmaceutical compositions comprising steroids and flavonoids
US3053836A (en) * 1961-07-14 1962-09-11 Olin Mathieson Acetals and ketals of 16alpha, 17alpha-dihydroxyprogesterones
US3541602A (en) * 1968-07-29 1970-11-17 Squibb & Sons Inc Acetonides of 9-halogenated 3beta,11beta,10alpha,17alpha,21-pentahydroxypregnanes
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base

Also Published As

Publication number Publication date
BE818929A (fr) 1975-02-17
FR2240738B1 (nl) 1980-04-11
JPS5058211A (nl) 1975-05-21
PH12415A (en) 1979-02-07
ZA744259B (en) 1975-06-25
HK44778A (en) 1978-08-18
AU7073674A (en) 1976-01-08
FR2240738A1 (nl) 1975-03-14
JPS557407B2 (nl) 1980-02-25
DE2437847B2 (de) 1980-06-19
US4158055A (en) 1979-06-12
DE2437847C3 (de) 1981-03-12
NL184899C (nl) 1989-12-01
CH601353A5 (nl) 1978-07-14
GB1442925A (en) 1976-07-14
NL184899B (nl) 1989-07-03
IE39738L (en) 1975-02-17
CY946A (en) 1978-06-23
IE39738B1 (en) 1978-12-20
HU172213B (hu) 1978-07-28
KE2820A (en) 1978-03-10
DE2437847A1 (de) 1975-02-27
NL7410613A (nl) 1975-02-19
IL45200A0 (en) 1974-11-29
IL45200A (en) 1978-08-31

Similar Documents

Publication Publication Date Title
ZA747964B (en) 2-cyclohexene-1-one derivatives
HK13379A (en) Pyrazino-isoquinoline derivatives
ZA744331B (en) 1-hydroxyphenyl-2-amidoalkylaminoesthanol derivatives
PH14530A (en) 7-methoxycephalosporin derivatives
HK44778A (en) Novel triamcinolone derivative
PH12927A (en) Vingamine derivatives
ZA745316B (en) Novel steroids
ZA743706B (en) Azapurinone derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
ZA738704B (en) Lactamimide derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
HK181A (en) Benzylpyrimidine derivatives
HK54080A (en) Dihydroergopeptine derivatives
ZM7974A1 (en) Nitro-heterocyclic derivatives
ZA744864B (en) Cyclohexane derivatives
ZA743084B (en) Pyrazinoisoquinoline derivative
ZA741229B (en) Nuceleoside derivatives
ZA747612B (en) Anhydrise derivatives
ZA745315B (en) Novel steroids
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
IE38121B1 (en) Novel triamcinolone derivative
ZA741439B (en) Benzenesulfonylurea derivatives
ZA746518B (en) Bis-thioreido benezne derivatives